PCM
CEMI

Perkins Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Perkins Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-267,980
Closed -$796K – 111
2021
Q2 		$796K Sell
267,980
-21,700
-7% -$75.6K 0.45% 60
2021
Q1 		$1.02M Buy
+289,680
New +$1.61M 0.59% 52
2020
Q1 		– Sell
-171,100
Closed -$780K – 122
2019
Q4 		$780K Sell
171,100
-22,200
-11% -$108K 0.7% 50
2019
Q3 		$1.18M Sell
193,300
-50,000
-21% -$298K 1.02% 35
2019
Q2 		$1.48M Sell
243,300
-29,350
-11% -$198K 1.04% 30
2019
Q1 		$1.51M Buy
272,650
+151,250
+125% +$983K 1% 32
2018
Q4 		$687K Buy
121,400
+27,050
+29% +$199K 0.53% 61
2018
Q3 		$991K Sell
94,350
-200
-0.2% -$2.15K 0.59% 53
2018
Q2 		$1.05M Buy
94,550
+20,050
+27% +$180K 0.75% 46
2018
Q1 		$596K Buy
74,500
+49,000
+192% +$392K 0.54% 58
2017
Q4 		$209K Sell
25,500
-10,000
-28% -$67.7K 0.2% 96
2017
Q3 		$220K Sell
35,500
-10,950
-24% -$67.4K 0.23% 81
2017
Q2 		$281K Sell
46,450
-3,000
-6% -$18.7K 0.31% 76
2017
Q1 		$262K Sell
49,450
-18,600
-27% -$108K 0.27% 85
2016
Q4 		$463K Buy
68,050
+1,350
+2% +$9.35K 0.51% 68
2016
Q3 		$494K Buy
+66,700
New +$481K 0.49% 67
2013
Q3 		– Sell
-54,000
Closed -$270K – 140
2013
Q2 		$270K Buy
+54,000
New +$250K 0.21% 100

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perkins Capital Management's CEMI Position: Q3 2021 in Review

Perkins Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2021, closing a stake of 267,980 shares — an estimated $796K sold.

Perkins Capital Management first reported a position in CEMI in Q2 2013 and held it in 17 quarters. The position peaked at $1.51M in Q1 2019. 47 funds tracked by Wall St. Rank hold CEMI as of Q3 2021.

  • Perkins Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Perkins Capital Management sold 267,980 Chembio diagnostics, Inc. shares in Q3 2021, an estimated $796K.
  • Perkins Capital Management first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 17 quarters.
  • Perkins Capital Management's Chembio diagnostics, Inc. position peaked at $1.51M in Q1 2019.
  • 47 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2021.

Based on Perkins Capital Management's 13F filing for Q3 2021, filed 25 Oct 2021.